Q4 represents fourth consecutive quarter of poor performance blamed on "delays," which are now expected to continue into FY2026ALOT shares are down >50% since the disastrous MTEX acquisition last May, ...

Q4 represents fourth consecutive quarter of poor performance blamed on “delays,” which are now expected to continue into FY2026 ...

This is despite the airline’s recent Q1 results, which beat analyst expectations for both revenue and earnings.

We recently published a list of the 11 Most Undervalued Quality Stocks to Buy Now. In this article, we are going to take a ...

Discover how we navigated surprises in Q1, updated our portfolio strategy, and reviewed performance, including insights on ...

LONDON (Reuters) -Trump administration cuts across federal health agencies have sent shivers through a biotech industry ...

Trump says the US is "doing really well on our tariff policy", following fluctuations in global stock markets.